
Tresivac 0.5ml Vaccine
Salt Composition: Measels,Mumps ,Rubella Vaccine
Expiry Date: 01/2028
Inclusive of all taxes
1
About The Product
Measels, Mumps, Rubella
Description
Tresivac 0.5ml Vaccine is a prescription based medicine. It is a combination of three vaccines such as Measles Vaccine (Live) (1000ccid50), Mumps Virus Vaccine (5000ccid50), and Rubella vaccine (Live) (1000ccid50).
It is used to prevent measles, mumps, and rubella. It works by stimulating the immune system to act against microorganisms to prevent such types of infection.
As these infections can occur in people of any age group so it is essential to take vaccine against them.
Uses
- Prevention of Measles
- Prevention of Rubella
- Prevention of Mumps
Side Effects
Most side effects of Tresivac 0.5ml Vaccine do not require medical attention as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.
Common side effects include:
- Injection site soreness
- Fever
How To Use
- Tresivac 0.5ml Vaccine should be given by an experienced nurse or doctor. Please do not self-administer. The first dose of this injection is usually given at 12 through 15 months of age. And the second dose is given at 4 through 6 years of age.
- Never skip any dose and don't forget to follow doctors instructions to get maximum benefit.
How It Works
- Tresivac 0.5ml Vaccine is a prescription based medicine. It is a combination of three vaccines such as Measles Vaccine (Live) (1000ccid50), Mumps Virus Vaccine (5000ccid50), and Rubella vaccine (Live) (1000ccid50).
- This vaccine helps to develop immunity by initiating a mild infection also this type of infection does not cause illness. Mild infection caused by vaccine stimulate the body's immune system to produce antibodies to protect against any future infections.
Safety Advice
FAQs
Tresivac 0.5ml Vaccine is used to prevent measles, mumps, and rubella.
References
- Di Pietrantonj, C., Rivetti, A., Marchione, P., Debalini, M. G., & Demicheli, V. (2020). Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database of Systematic Reviews, (4). https://pubmed.ncbi.nlm.nih.gov/34806766/
- Sood, A., Mitra, M., Joshi, H. A., Nayak, U. S., Siddaiah, P., Babu, T. R., ... & Glueck, R. (2017). Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27/3 rubella strain: Results of a randomized, comparative, active controlled phase III clinical trial. Human Vaccines & Immunotherapeutics, 13(7), 1523-1530. https://pubmed.ncbi.nlm.nih.gov/28362563/
- Larenas-Linnemann, D. E., & Rodríguez-Monroy, F. (2021). Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course. Allergy, 76(3), 910-914. https://pubmed.ncbi.nlm.nih.gov/32894782/
- Shah, A. K. (2019). 3.8 MEASLES, MUMPS, AND RUBELLA VACCINES. IAP Guidebook on Immunization, 227.
- Agrawal, R. (2021). 21 Measles, Mumps and Rubella Vaccines MR/MMR/MMRV Vaccines. IAP Q & A on Vaccines & Vaccinology, 204.
Medical Disclaimer
Accurate, reviewed information to support informed healthcare decisions
Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.
The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.
This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.
Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.
